Literature DB >> 24117926

Dermal changes in superficial basal cell carcinoma, melanoma in situ and actinic keratosis and their implications.

Viktoryia Kazlouskaya1, Saurabh Malhotra, Raquel Navarro, Karen Nguyen Wu, Marianna Shvartsbeyn, Chen Shengli, Jiang Gui, Dirk M Elston.   

Abstract

BACKGROUND: Basal cell carcinoma (BCC) has a characteristic stroma, but less is known about the dermal characteristics associated with melanoma in situ (MIS) and actinic keratosis (AK).
MATERIALS AND METHODS: Dermal changes were studied in 301 specimens of AK, BCC and MIS. Subsequently, blinded images of dermal changes from 90 randomly selected cases of those entities were used to assess the predictive value of the dermal changes. Agreement with the final diagnosis was calculated using kappa coefficient (κ).
RESULTS: Fibromyxoid stroma was present in 82% of BCC cases; fibrous stroma was seen in 25% of BCC, 58% of MIS and 35.6% of AK specimens (p < 0.05). A lichenoid inflammatory infiltrate was frequently associated with AK and a perifollicular infiltrate with periadnexal fibrosis with MIS. Blinded evaluation of images of the dermal changes associated with the tumors yielded the correct diagnosis in (54.4, 41.1 and 27.8%; average 41.2%) by the three appraisers. Coefficient of agreement in blinded imaged evaluation with the actual diagnosis was higher in the BCC and MIS compared with AK (κ = 0.37, p = 0.0001; κ = 0.2, p = 0.0005 and κ = -0.06, p = 0.84, respectively).
CONCLUSION: Dermal features may be helpful in predicting the correct diagnosis when tumor is not visible.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; malignant melanoma; non-melanoma skin cancer; pathology; pathology dermatopathology

Mesh:

Year:  2013        PMID: 24117926      PMCID: PMC5980638          DOI: 10.1111/cup.12235

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  15 in total

1.  Selectively enhanced procollagen gene expression in sclerosing (morphea-like) basal cell carcinoma as reflected by elevated pro alpha 1(I) and pro alpha 1(III) procollagen messenger RNA steady-state levels.

Authors:  R L Moy; L S Moy; L Y Matsuoka; R G Bennett; J Uitto
Journal:  J Invest Dermatol       Date:  1988-05       Impact factor: 8.551

2.  Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.

Authors:  Prahbjot Kaur; Michael Mulvaney; J Andrew Carlson
Journal:  Am J Dermatopathol       Date:  2006-08       Impact factor: 1.533

3.  Epithelial tumor, invasion and stroma.

Authors:  Masutaka Furue
Journal:  Ann Dermatol       Date:  2011-05-27       Impact factor: 1.444

4.  Hypertrophic actinic keratosis.

Authors:  R A Billano; W P Little
Journal:  J Am Acad Dermatol       Date:  1982-10       Impact factor: 11.527

Review 5.  Lentiginous melanoma.

Authors:  Roy King
Journal:  Arch Pathol Lab Med       Date:  2011-03       Impact factor: 5.534

6.  Contiguous lesions in lentigo maligna.

Authors:  Scott R Dalton; Timothy L Gardner; Lester F Libow; Dirk M Elston
Journal:  J Am Acad Dermatol       Date:  2005-05       Impact factor: 11.527

7.  Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.

Authors:  Ossama Abbas; Joanna E Richards; Meera Mahalingam
Journal:  Mod Pathol       Date:  2010-08-13       Impact factor: 7.842

8.  Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression.

Authors:  J A Reed; N S McNutt; A P Albino
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

9.  Is superficial spreading melanoma still the most common form of malignant melanoma?

Authors:  Seth B Forman; Tammie C Ferringer; Steven J Peckham; Scott R Dalton; Geoff T Sasaki; Lester F Libow; Dirk M Elston
Journal:  J Am Acad Dermatol       Date:  2008-06       Impact factor: 11.527

10.  Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes.

Authors:  Kyle Lesack; Christopher Naugler
Journal:  BMC Dermatol       Date:  2012-03-09
View more
  3 in total

Review 1.  Novel approaches to imaging basal cell carcinoma.

Authors:  Anthony M Rossi; Heidy Sierra; Milind Rajadhyaksha; Kiswher Nehal
Journal:  Future Oncol       Date:  2015-10-15       Impact factor: 3.404

Review 2.  MiR-21: an environmental driver of malignant melanoma?

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2015-06-27       Impact factor: 5.531

Review 3.  Usefulness of Photodynamic Therapy as a Possible Therapeutic Alternative in the Treatment of Basal Cell Carcinoma.

Authors:  Paola Savoia; Tommaso Deboli; Alberto Previgliano; Paolo Broganelli
Journal:  Int J Mol Sci       Date:  2015-09-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.